Literature DB >> 25785949

Focus on early detection to reduce melanoma deaths.

Alan C Geller1, Susan M Swetter2, Martin A Weinstock3.   

Abstract

Thin fatal melanomas are a relatively new clinical and public health concern, representing an estimated 20% of melanoma deaths. Understanding this phenomenon will require a multi-pronged approach, including in-depth investigation of its behavioral and biological underpinnings. As we proceed with relevant studies, the benefits in lives saved will grow via early detection.

Entities:  

Mesh：

Year:  2015        PMID： 25785949     DOI： 10.1038/jid.2014.534

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  7 in total

1.  Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death?

Authors:  Rajmohan Murali; Richard A Scolyer; John F Thompson
Journal:  Ann Surg Oncol       Date:  2012-07-10       Impact factor: 5.344

Review 2.  Prognostication in thin cutaneous melanomas.

Authors:  Phyllis A Gimotty; DuPont Guerry
Journal:  Arch Pathol Lab Med       Date:  2010-12       Impact factor: 5.534

3.  More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia.

Authors:  David C Whiteman; Peter D Baade; Catherine M Olsen
Journal:  J Invest Dermatol       Date:  2014-10-20       Impact factor: 8.551

4.  Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.

Authors:  Alexander Katalinic; Annika Waldmann; Martin A Weinstock; Alan C Geller; Nora Eisemann; Ruediger Greinert; Beate Volkmer; Eckhard Breitbart
Journal:  Cancer       Date:  2012-04-19       Impact factor: 6.860

5.  Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

6.  Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.

Authors:  Jeffrey S Schneider; Dan H Moore; Mortimer L Mendelsohn
Journal:  J Am Acad Dermatol       Date:  2008-02-20       Impact factor: 11.527

7.  Melanoma thickness trends in the United States, 1988-2006.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  J Invest Dermatol       Date:  2009-10-15       Impact factor: 8.551
  7 in total
  5 in total

1.  Screening for reducing morbidity and mortality in malignant melanoma.

Authors:  Minna Johansson; John Brodersen; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2019-06-03

2.  Generation of metastatic melanoma specific antibodies by affinity purification.

Authors:  Birgit Schütz; Anita Koppensteiner; David Schörghofer; Katharina Kinslechner; Gerald Timelthaler; Robert Eferl; Markus Hengstschläger; Albert Missbichler; Harald Hundsberger; Mario Mikula
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

3.  Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles.

Authors:  June K Robinson; Samer Wahood; Sophia Ly; Jessie Kirk; Jamie Yoon; James Sterritt; Elizabeth Gray; Mary Kwasny
Journal:  Prev Med Rep       Date:  2021-08-26

4.  Use of and intentions to use dermoscopy among physicians in the United States.

Authors:  Jeffrey B Morris; Sara V Alfonso; Nilda Hernandez; M Isabel Fernández
Journal:  Dermatol Pract Concept       Date:  2017-04-30

5.  A Non-Invasive Interpretable Diagnosis of Melanoma Skin Cancer Using Deep Learning and Ensemble Stacking of Machine Learning Models.

Authors:  Iftiaz A Alfi; Md Mahfuzur Rahman; Mohammad Shorfuzzaman; Amril Nazir
Journal:  Diagnostics (Basel)       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.